The Ski protein negatively regulates Siah2-mediated HDAC3 degradation

Biochemical and Biophysical Research Communications

Volumn 399, Issue 4, 2010, Pages 623-628

  Zhao, Hong Ling ^a   Ueki, Nobuhide ^a   Hayman, Michael J ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Co repressor complex; HDAC3; Proteasomal degradation; Siah2; Ski

Indexed keywords

BINDING PROTEIN; HISTONE DEACETYLASE 3; PROTEASOME; RETINOIC ACID RECEPTOR ALPHA; SIAH2 PROTEIN; SKI PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; DNA BINDING PROTEIN; HISTONE DEACETYLASE; LEUPEPTIN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEASOME INHIBITOR; SEVEN IN ABSENTIA PROTEINS; SKI PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; ENZYME ACTIVITY; ENZYME DEGRADATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; WESTERN BLOTTING; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; ENZYME STABILITY; GENETICS; HUMAN; METABOLISM;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTEINE PROTEINASE INHIBITORS; DNA-BINDING PROTEINS; ENZYME STABILITY; HISTONE DEACETYLASES; HUMANS; IMMUNOPRECIPITATION; LEUPEPTINS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; UBIQUITIN-PROTEIN LIGASES; PROTEASOME INHIBITORS;

EID: 77956262579     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.127     Document Type: Article

References (28)

1. Dahl R., Kieslinger M., Beug H., Hayman M.J. Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. Proc. Natl. Acad. Sci. USA 1998, 95:11187-11192.
2. Ritter M., Kattmann D., Teichler S., Hartmann O., Samuelsson M.K., Burchert A., Bach J.P., Kim T.D., Berwanger B., Thiede C., Jager R., Ehninger G., Schafer H., Ueki N., Hayman M.J., Eilers M., Neubauer A. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 2006, 20:437-443.
3. Ueki N., Hayman M.J. Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J. Biol. Chem. 2003, 278:24858-24864.
4. Nomura T., Khan M.M., Kaul S.C., Dong H.D., Wadhwa R., Colmenares C., Kohno I., Ishii S. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev. 1999, 13:412-423.
5. Perissi V., Aggarwal A., Glass C.K., Rose D.W., Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004, 116:511-526.
6. Zhao H.L., Ueki N., Marcelain K., Hayman M.J. The Ski protein can inhibit ligand induced RARalpha and HDAC3 degradation in the retinoic acid signaling pathway. Biochem. Biophys. Res. Commun. 2009, 383:119-124.
7. Boudjelal M., Wang Z., Voorhees J.J., Fisher G.J. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res. 2000, 60:2247-2252.
8. Kopf E., Plassat J.L., Vivat V., de The H., Chambon P., Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J. Biol. Chem. 2000, 275:33280-33288.
9. Osburn D.L., Shao G., Seidel H.M., Schulman I.G. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. Mol. Cell. Biol. 2001, 21:4909-4918.
10. Tanaka T., Rodriguez de la Concepcion M.L., De Luca L.M. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem. Pharmacol. 2001, 61:1347-1355.
11. Gianni M., Bauer A., Garattini E., Chambon P., Rochette-Egly C. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. EMBO J. 2002, 21:3760-3769.
12. Gianni M., Tarrade A., Nigro E.A., Garattini E., Rochette-Egly C. The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers. J. Biol. Chem. 2003, 278:34458-34466.
13. Bour G., Lalevee S., Rochette-Egly C. Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors. Trends Cell Biol. 2007, 17:302-309.
14. Zhao J., Zhang Z., Vucetic Z., Soprano K.J., Soprano D.R. HACE1: a novel repressor of RAR transcriptional activity. J. Cell. Biochem. 2009, 107:482-493.
15. Anglesio M.S., Evdokimova V., Melnyk N., Zhang L., Fernandez C.V., Grundy P.E., Leach S., Marra M.A., Brooks-Wilson A.R., Penninger J., Sorensen P.H. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney. Hum. Mol. Genet. 2004, 13:2061-2074.
16. Zhang J., Guenther M.G., Carthew R.W., Lazar M.A. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev. 1998, 12:1775-1780.
17. Ritter M., Kattmann D., Teichler S., Hartmann O., Samuelsson M.K., Burchert A., Bach J.P., Kim T.D., Berwanger B., Thiede C., Jager R., Ehninger G., Schafer H., Ueki N., Hayman M.J., Eilers M., Neubauer A. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 2006, 3:437-443.
18. Marcelain K., Hayman M.J. The Ski oncoprotein is upregulated and localized at the centrosomes and mitotic spindle during mitosis. Oncogene 2005, 24:4321-4329.
19. Ueki N., Zhang L., Hayman M.J. Ski can negatively regulates macrophage differentiation through its interaction with PU.1. Oncogene 2008, 27:300-307.
20. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 2001, 70:503-533.
21. Moller A., House C.M., Wong C.S., Scanlon D.B., Liu M.C., Ronai Z., Bowtell D.D. Inhibition of Siah ubiquitin ligase function. Oncogene 2009, 28:289-296.
22. Depaux A., Regnier-Ricard F., Germani A., Varin-Blank N. Dimerization of hSiah proteins regulates their stability. Biochem. Biophys. Res. Commun. 2006, 348:857-863.
23. Habelhah H., Frew I.J., Laine A., Janes P.W., Relaix F., Sassoon D., Bowtell D.D., Ronai Z. Stress-induced decrease in TRAF2 stability is mediated by Siah2. EMBO J. 2002, 21:5756-5765.
24. Dennis A.P., Haq R.U., Nawaz Z. Importance of the regulation of nuclear receptor degradation. Front. Biosci. 2001, 6:D954-D959.
25. Hu G., Fearon E.R. Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins. Mol. Cell. Biol. 1999, 19:724-732.
26. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 1999, 96:11364-11369.
27. Szargel R., Rott R., Eyal A., Haskin J., Shani V., Balan L., Wolosker H., Engelender S. Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation. J. Biol. Chem. 2009, 284:11706-11716.
28. Park T.J., Hamanaka H., Ohshima T., Watanabe N., Mikoshiba K., Nukina N. Inhibition of ubiquitin ligase Siah-1A by disabled-1. Biochem. Biophys. Res. Commun. 2003, 302:671-678.